1097O The AXINET trial (GETNE1107): Axitinib plus octreotide LAR improves PFS by blinded central radiological assessment vs placebo plus octreotide LAR in G1-2 extrapancreatic NETs
暂无分享,去创建一个
F. Spada | D. Castellano | R. García-Carbonero | J. Capdevila | E. Grande | S. Tafuto | T. Ibrahim | E. González-Flores | T. Alonso-Gordoa | A. Carmona-Bayonas | M. Benavent | A. Custodio | P. García-Alfonso | V. Iranzo | P. Fonseca | A. Casta | G. Crespo | A. Teule | C. López | M. J. V. Silva